[Asia Economy Reporter Jang Hyowon] Nexten Bio announced on the 15th that it will attend the "Post-Pandemic Era Preparedness, Optimal Response Measures to Viruses Conference" hosted by JoongAng Ilbo and the Chumakov Immunobiology Center.


The conference will be held at the Crystal Ballroom of Lotte Hotel Seoul at 2 PM on the 15th, where the development overview of the 'Covivac' vaccine developed by the Chumakov Institute will be presented, and in-depth discussions will take place regarding the government's safe COVID-19 vaccination and the prompt formation of herd immunity under the current circumstances.


The total number of attendees has not been disclosed, but it is known that key personnel from the Chumakov Institute, including Director Aidar, the Deputy Director, two technical staff, MPC officials, Nexten Bio representatives, as well as corporate and government officials involved in COVID vaccine development, will participate.



A Nexten Bio representative said, "We have high expectations for attending a forum to discuss overall issues related to the COVID-19 vaccine," adding, "We will do our best to explore cooperative measures to ensure efficient contract manufacturing, distribution, and sales of the vaccine to conquer COVID-19."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing